Two N-terminally truncated variants of human beta-galactoside alpha 2,6 sialyltransferase I with distinct properties for in vitro protein glycosylation

导出原文传递

翻译打印收藏纠错

作者： Luley-Goedl, Christiane ^[1] ; Schmoelzer, Katharina ^[2] ; Thomann, Marco ^[3] ; Malik, Sebastian ^[4] ; Greif, Michael ^[5] ; Ribitsch, Doris ^[6] ; Jung, Christine ; Sobek, Harald ; Engel, Alfred ; Mueller, Rainer ; Schwab, Helmut ; Nidetzky, Bernd

作者单位： Roche Diagnost GmbH, Pharma Tech Dev Fermentat, Nonnenwald 2, D-82377 Penzberg, Germany ^[1] Roche Diagnost GmbH, Pharma Tech Dev Analyt Biol, Nonnenwald 2, D-82377 Penzberg, Germany ^[2] Graz Univ Technol, Inst Mol Biotechnol, Petersgasse 14, A-8010 Graz, Austria ^[3] Austrian Ctr Ind Biotechnol, Petersgasse 14, A-8010 Graz, Austria ^[4] Roche Diagnost GmbH, Costum Biotech, Nonnenwald 2, D-82377 Penzberg, Germany ^[5] Lab Dr Merk & Kollegen GmbH, Beim Braunland 1, D-88416 Ochsenhausen, Germany ^[6]

关键词 antibody glycoengineering human beta-galactoside alpha 2 6-sialyltransferase in vitro protein glycosylation N-terminal truncation

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交